Expression of CD44 Variant 6 (V6) in endometrial cancer, endometrial hyperplasia, and normal endometrium
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 송재윤 | - |
dc.contributor.author | 박현태 | - |
dc.contributor.author | 이낙우 | - |
dc.contributor.author | 김영태 | - |
dc.contributor.author | 김인선 | - |
dc.contributor.author | 이규완 | - |
dc.date.available | 2020-11-10T15:47:47Z | - |
dc.date.issued | 2002 | - |
dc.identifier.issn | 2287-8572 | - |
dc.identifier.issn | 2287-8580 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/32529 | - |
dc.format.extent | 1 | - |
dc.title | Expression of CD44 Variant 6 (V6) in endometrial cancer, endometrial hyperplasia, and normal endometrium | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | Obstetrics & Gynecology Science, v.45, no.9, pp 2 - 2 | - |
dc.citation.title | Obstetrics & Gynecology Science | - |
dc.citation.volume | 45 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 2 | - |
dc.citation.endPage | 2 | - |
dc.identifier.kciid | ART001211825 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kciCandi | - |
dc.subject.keywordAuthor | CD44 V6 | - |
dc.subject.keywordAuthor | Endometrial cancer | - |
dc.subject.keywordAuthor | Endometrial hyperplasia | - |
dc.subject.keywordAuthor | Normal endometrium | - |
dc.subject.keywordAuthor | Immunohisto- chemistry | - |
dc.subject.keywordAuthor | 자궁내막암 | - |
dc.subject.keywordAuthor | 자궁내막증식증 | - |
dc.subject.keywordAuthor | 정상자궁내막 | - |
dc.subject.keywordAuthor | 면역조직화학 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.